Author:
Vacca Fabrizio,Yalcin Binnaz,Ansar Muhammad
Abstract
Cohen Syndrome (CS) is a rare autosomal recessive disorder caused by biallelic mutations in the VPS13B gene. It is characterized by multiple clinical features, including acquired microcephaly, developmental delay, intellectual disability, neutropenia, and retinal degeneration. VPS13B is part of the bridge-like lipid transport (BLTP) protein family, which in mammals also includes VPS13A, -C, and -D. The proteins of this family are peripheral membrane proteins with different sub-cellular localization, but all share similar structural features and have been proposed to act as lipid transport proteins at organellar membrane contact sites. VPS13B is localized at the Golgi apparatus and is essential for the maintenance of organelle architecture. Here we present a review of the experimental data on the function of the protein at the cellular level, discussing the potential link with disease phenotype and review the studies on animal models recapitulating features of the human disease.
Reference56 articles.
1. Mutations in the Vps13B gene in Iranian patients with different phenotypes of Cohen syndrome;Alipour;J. Mol. Neurosci.,2020
2. A Gwas in Latin Americans identifies novel face shape loci, implicating Vps13B and a Denisovan introgressed region in facial variation;Bonfante;Sci. Adv.,2021
3. In situ architecture of the lipid transport protein Vps13C at Er-lysosome membrane contacts;Cai;Proc. Natl. Acad. Sci. USA,2022
4. A genomic mutational constraint map using variation in 76,156 human genomes;Chen;Nature,2024
5. A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies;Cohen;J. Pediatr.,1973